Cargando…
Cerebroprotein hydrolysate attenuates neurodegenerative changes in Alzheimer’s mice model via ferroptosis pathway
Introduction: Cerebroprotein hydrolysate has been proven to improve cognitive function in patients with Alzheimer’s disease (AD). We explored the safety and effectiveness of the clinical administration of oral cerebroprotein hydrolysate in AD, and possible mechanisms related to the neuronal ferropto...
Autores principales: | Chen, Moxi, Song, Wei, Chen, Zhengju, Shi, Xiaodong, Wang, Xue, Li, Rongrong, Hao, Honglin, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154667/ https://www.ncbi.nlm.nih.gov/pubmed/37153800 http://dx.doi.org/10.3389/fphar.2023.1177503 |
Ejemplares similares
-
CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
por: Liu, Zehui, et al.
Publicado: (2019) -
Cerebroprotein hydrolysate‐I protects senescence‐induced by D‐galactose in PC12 cells and mice
por: Zhu, Lin, et al.
Publicado: (2021) -
Transcriptome Analysis Reveals the Effects of Troxerutin and Cerebroprotein Hydrolysate Injection on Injured Spinal Cords in Rats
por: Wang, Linbang, et al.
Publicado: (2020) -
Cerebroprotein Hydrolysate-I Inhibits Hippocampal Neuronal Apoptosis by Activating PI3K/Akt Signaling Pathway in Vascular Dementia Mice
por: Wu, Xiaolin, et al.
Publicado: (2021) -
Protective effect of troxerutin and cerebroprotein hydrolysate injection on cerebral ischemia through inhibition of oxidative stress and promotion of angiogenesis in rats
por: Ma, Wenbing, et al.
Publicado: (2019)